Found 20 matching trials
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy N/A Hormone receptor-positive breast cancer accounts for about 70% of all breas...
Show More Location
Cancer Hospital Affiliated to Harbin Medical University
Learn More & Join Trial
OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk PHASE4 Among ER+HER2- premenopausal patients with N1 who undergoes primary breast ...
Show More Location
Gangnam Severance Hospital
Learn More & Join Trial
CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer PHASE3 The investigators designed a phase III clinical trial involving hormone rec...
Show More Location
Multiple Locations
Learn More & Join Trial
ENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer Patients N/A The principal aim of this prospective observational study is to investigate...
Show More Location
IRCCS Ospedale Policlinico San Martino
Learn More & Join Trial
Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study N/A This study aims to enroll premenopausal patients, with early breast cancer ...
Show More Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Learn More & Join Trial
Fulvestaciclib Combined With Anti-HER2 and Endocrine Therapy for HR+/HER2+ Advanced Breast Cancer PHASE2 This phase II, multicenter, open-label, randomized controlled trial (FACET ...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 PHASE3 This Phase III Trial will determine whether adjuvant chemotherapy (ACT) add...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer PHASE2 The purpose of this study is to perform an in depth analysis of changes in ...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Entinostat Plus Pyrotinib and Endocrine Therapy in Advanced Triple-Positive Breast Cancer After Trastuzumab Failure PHASE1 This is an open-label, single-center, exploratory, Phase Ib/II clinical tri...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women PHASE3 The objective of this study is to compare the curative effects in patients ...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial